Generative AI Innovation Pharmaceuticals 
AWS Machine Learning - AI
MARCH 4, 2024
Amazon Bedrock is the best place to build and scale generative AI applications with large language models (LLM) and other foundation models (FMs). It enables customers to leverage a variety of high-performing FMs, such as the Claude family of models by Anthropic, to build custom generative AI applications.
AWS Machine Learning - AI
FEBRUARY 6, 2024
Bringing innovative new pharmaceuticals drugs to market is a long and stringent process. Accenture built a regulatory document authoring solution using automated generative AI that enables researchers and testers to produce CTDs efficiently. AI delivers a major leap forward.
CIO
MARCH 21, 2023
As the generative AI bandwagon gathers pace , Nvidia is promising tools to accelerate it still further. On March 21, CEO Jensen Huang (pictured) told attendees at the company’s online-only developer conference, GTC 2023, about a string of new services Nvidia hopes enterprises will use to train and run their own generative AI models.
Cloudera
JUNE 11, 2024
More than two-thirds of companies are currently using Generative AI (GenAI) models, such as large language models (LLMs), which can understand and generate human-like text, images, video, music, and even code. A global pharmaceutical company has utilized GenAI to accelerate drug discovery and development.
Crunchbase News
JULY 19, 2024
Yep, no huge AI raise. Cardurion Pharmaceuticals , $260M, biotech: Cardurion Pharmaceuticals led the way for biotech startups raising big money this week, as the Burlington, Massachusetts-based biotech firm raised a $260 million Series B financing led by Ascenta Capital. Notice anything missing? went to a startup down under.
John Snow Labs
AUGUST 7, 2024
Generative AI in healthcare is a transformative technology that utilizes advanced algorithms to synthesize and analyze medical data, facilitating personalized and efficient patient care. Generative AI models now play a role, in drug discovery and development by reducing time and costs associated with bringing new medications to market.
CIO
DECEMBER 18, 2023
Over the summer, I wrote a column about how CIOs are worried about the informal rise of generative AI in the enterprise. Since then, many CIOs I’ve spoken with have grappled with enterprise data security and privacy issues around AI usage in their companies. That column may have been the understatement of the year.
Expert insights. Personalized for you.
139 
Let's personalize your content